[1]许教雄,何仁亮,李凤春,等.聚桂醇泡沫硬化剂治疗颜面部皮脂腺囊肿的临床观察[J].中国皮肤性病学杂志,2019,(07):858-862.[doi:10.13735/j.cjdv.1001-7089.201812084]
 XU Jiaoxiong,HE Renliang,LI Fengchun,et al.Clinical Observation on Lauromacrogol Foam Sclerotherapy in the Treatment of Facial Sebaceous Cyst[J].The Chinese Journal of Dermatovenereology,2019,(07):858-862.[doi:10.13735/j.cjdv.1001-7089.201812084]
点击复制

聚桂醇泡沫硬化剂治疗颜面部皮脂腺囊肿的临床观察
分享到:

《中国皮肤性病学杂志》[ISSN:1001-7089/CN:61-1197/R]

卷:
期数:
2019年07期
页码:
858-862
栏目:
药物与临床
出版日期:
2019-06-16

文章信息/Info

Title:
Clinical Observation on Lauromacrogol Foam Sclerotherapy in the Treatment of Facial Sebaceous Cyst
文章编号:
1001-7089(2019)07-0858-05
作者:
许教雄1何仁亮23李凤春1黄桃源23
1.中山市黄圃人民医院皮肤科,广东 中山 528429; 2.南方医科大学皮肤病医院,广东 广州 510091; 3.广东省皮肤病医院,广东 广州 510091
Author(s):
XU Jiaoxiong1HE Renliang23LI Fengchun1HUANG Taoyuan23
(1.Department of Dermatology,Huangpu People's Hospital of Zhongshan City,Zhongshan 528429,Guangdong,China; 2.Dermatology Hospital of Southern Medical University,Guangzhou 510091,China; 3.Guangdong Provincial Dermatology Hospital,Guangzhou 510091,China)
关键词:
颜面部 皮脂腺囊肿 聚桂醇泡沫硬化剂 复方倍他米松注射液
Keywords:
Facial Sebaceous cyst Lauromacrogol foam sclerotherapy Compound betamethasone injection
分类号:
R 758.73
DOI:
10.13735/j.cjdv.1001-7089.201812084
文献标志码:
B
摘要:
目的 观察聚桂醇泡沫硬化剂治疗颜面部皮脂腺囊肿的临床疗效。方法 对62例颜面部皮脂腺囊肿的患者,随机分为观察组与对照组,两组患者均采用微创穿刺搔刮术清除囊内容物,庆大霉素注射液及生理盐水冲洗,观察组患者采用聚桂醇泡沫硬化剂囊腔内注射,对照组患者采用复方倍他米松注射液囊腔内注射。于首次治疗后第4、8周复诊,观察两组患者的治疗效果及复治情况,于第12周评价临床疗效及不良反应情况,治疗结束后6个月内随访观察复发率及皮损情况。结果 首次治疗后第8、12周两组间囊肿直径及第8周复治例数比较,差异均有统计学意义(P<0.05); 两组第12周临床疗效、不良反应及治疗结束后6个月内复发例数比较,差异有统计学意义(P<0.05); 观察组有效率高于对照组,临床疗效优于对照组,皮损表面不良反应低于对照组。结论 聚桂醇泡沫硬化剂注射治疗颜面部皮脂腺囊肿,疗效优越,创伤小、复发率低。
Abstract:
Objective To observe the clinical efficacy of lauromacrogol foam sclerotherapy in the treatment of facial sebaceous cyst.Methods A total of 62 patients with facial sebaceous cyst were randomly divided into observation group and control group.All the patients underwent minimally invasive puncture and scraping to remove the contents of sebaceous cyst,which was then rinsed using gentamicin injection and physiological saline.Subsequently,the observation group was treated with lauromacrogol foam sclerotherapy for cystic cavity injection,while the control group was treated by compound betamethasone injection for cystic cavity injection.The efficacy and retreatment of all patients were observed at 4 and 8 weeks after initial treatment,and the clinical curative effect and adverse reaction were evaluated at 12 weeks after treatment.The relapse rate and the lesions were followed up in 6 months after completion of treatment.Results There were significant differences in the cyst diameter at 8 and 12 weeks after initial treatment and the retreatment cases at 8 weeks between the two groups(P<0.05).Significant differences were found in the clinical curative effect and adverse reactions at 12 weeks after treatment and in the number of relapse cases in 6 months after the completion of treatment in both groups(P<0.05).The effective rate and the clinical curative effect of the observation group were higher and skin surface adverse reaction was lower than those of the control group.Conclusion For the treatment of facial sebaceous cyst,lauromacrogol foam sclerotherapy has advantages of excellent curative effect,minimal trauma,great safety,beautiful incision and low relapse rate.

参考文献/References:

[1] 秦增辉,林晓曦,骆泉丰.微创硬化治疗技术指南[J].微创医学,2012,7(6):573-581.
[2] 郑胜武,郑清健,黄雄梅.面颈部皮脂腺囊肿的美容性治疗临床探讨[J].中国美容医学,2016,25(8):5-8.
[3] 热娜古孜·阿不都米吉提,陈伟良,黄志权,等.微小切口排溢囊内物后摘除皮脂腺囊肿的效果评价[J].中国口腔颌面外科杂志,2017,15(4):365-367.
[4] 陈泽凯.113例皮脂腺囊肿的治疗体会[J].深圳中西医结合杂志,2017,27(16):97-99.
[5] 蔡仁慧,吕萍.聚桂醇泡沫硬化剂治疗婴幼儿血管瘤79例临床观察[J].中国皮肤性病学杂志,2017,31(7):740-742.
[6] Naik MN,Batra J,Nair AG,et al.Foam sclerotherapy for periorbital dermoid cysts[J].Ophthalmic Plast Reconstr Surg,2014,30(3):267-270.
[7] 蔡源源,李新庆,陆洁慧,等.针状切口联合聚桂醇治疗皮脂腺囊肿58例[J].中华皮肤科杂志,2017,50(10):756-757.
[8] 罗军,李安华,周红雁,等.新型硬化剂聚桂醇治疗体表囊性病变的临床观察[J].中国普通外科杂志,2012,21(12):1601-1602.
[9] Zimmet SE.Selerotherapy treatment of telangiectasias and varicose veins[J].Tech Vasc Interv Radiol,2003,6(3):116-120.
[10] 郭光良,李建国,张英,等.穿刺联合复方倍他米松囊内注射治疗耳廓假性囊肿77例[J].人民军医,2016,59(10):1055-1056.
[11] JohnB,Van LC.泡沫硬化剂疗法教程[M].李龙,译.北京:人民军医出版社,2009:248.
[12] 郑艳,徐春丽.聚桂醇400临床应用进展[J].医药导报,2012,31(2):190-192.
[13] Cavezzi A,Parsi K.Complications of foam sclerotherapy[J].Phlebology,2012,27(1):46-51.

相似文献/References:

[1]李红,李冰菲,刘伟伟,等.儿童孪生兄弟同患颜面播散性粟粒性狼疮并文献回顾[J].中国皮肤性病学杂志,2018,(08):914.[doi:10.13735/j.cjdv.1001-7089.201801105]
 LI Hong,LI Bingfei,LIU Weiwei,et al.Lupus Miliaris Disseminatus Faciei in Twin Brothers: a Case Report and Literature Review[J].The Chinese Journal of Dermatovenereology,2018,(07):914.[doi:10.13735/j.cjdv.1001-7089.201801105]

备注/Memo

备注/Memo:
[作者单位] 1.中山市黄圃人民医院皮肤科,广东 中山 528429; 2.南方医科大学皮肤病医院,广东 广州 510091; 3.广东省皮肤病医院,广东 广州 510091
[通讯作者] 何仁亮,E-mail:1304974336@qq.com
[Corresponding author] HE Renliang,E-mail:1304974336@qq.com
更新日期/Last Update: 2019-06-15